Low-molecular-weight heparins for acute coronary syndromes: an emergency medicine perspective.
Patients with chest pain represent one of the largest and most challenging populations for emergency departments to treat. Diagnostic and treatment modalities implemented in the emergency department are associated with significant clinical outcomes and financial implications. Critical pathways are being developed to increase the speed and efficiency with which these patients are managed. Of particular importance is the evolving role of low-molecular-weight heparins, which have both clinical and economic advantages over unfractionated heparins in treating unstable angina and non-Q wave myocardial infarction.
Gonzalez
E R
ER
Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
D000208:Acute Disease; D000789:Angina, Unstable / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D004632:Emergency Medical Services / Q000191:economics* / Q000592:standards*; D006493:Heparin / Q000191:economics / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D013997:Time Factors
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin